Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Preclinical Evaluation of Soluble Epoxide Hydrolase Inhibitor AMHDU against Neuropathic Pain

International Journal of Molecular Sciences(2024)10.3390/ijms25168841Source: DataRank Database

Preclinical Evaluation of Soluble Epoxide Hydrolase Inhibitor AMHDU against Neuropathic Pain is a research paper published in International Journal of Molecular Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: goldTopics (60)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Natalya V. Eliseeva ORCID,Kristina I. Adzhienko,Viktoria Bagmetova,Д. В. Данилов ORCID,Cynthia B. McReynolds

Live enrichment

PubMed:39201526 PMC:PMC11354909

Russian Science Foundation

Grant: 19-73-10002

Russian Science Foundation

Grant: 124021500036-6

Russian Science Foundation

Grant: R35 ES030443

Russian Science Foundation

Grant: P42 ES004699

Russian Science Foundation

Grant: 2-SRA-2022-1210-S-B

National Institutes of Health

Grant: 5R35ES030443-04

Bioactive lipids as effectors and indicators of the deleterious effects of environmental exposure on chronic diseases

National Institutes of Health

Grant: 5P42ES004699-30

Biomarkers of Exposure to Hazardous Substances

goldLicense: cc-by

publisherhttps://www.mdpi.com/1422-0067/25/16/8841/pdf?version=1723625699

publisherhttps://www.mdpi.com/1422-0067/25/16/8841/pdf

repositoryhttps://escholarship.org/content/qt5620423h/qt5620423h.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11354909/pdf/ijms-25-08841.pdf

Unpaywallhttps://doi.org/10.3390/ijms25168841

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsMiceRatsNeuralgiaHyperalgesiaDiabetic NeuropathiesDisease Models, AnimalEdemaAdamantaneUreaEpoxide HydrolasesAnalgesicsEnzyme InhibitorsDrug Evaluation, PreclinicalMale

Keywords

UreaInhibitorSoluble Epoxide HydrolaseAdamantanePreclinical EvaluationMaleDrug Evaluation, PreclinicalNeurodegenerativeMiceDiabetic NeuropathiesMedicinal and biomolecular chemistryEdemaEnzyme InhibitorsEpoxide HydrolasesAnalgesicsDiabetesPain ResearchBiological SciencesPreclinical5.1 PharmaceuticalsHyperalgesiaNeurologicalChronic Pain610MicrobiologyArticle617GeneticsAnimalsPeripheral NeuropathyChemical PhysicsAnimalNeurosciencesRatsDisease Models, AnimalBiochemistry and cell biologyChemical SciencesDisease ModelsDrug EvaluationNeuralgiaOther Biological SciencesOther Chemical Sciences

Sustainable Development Goals

SDG 3: 3. Good health